Safer in care: A pandemic-tested model of integrated HIV/OUD care
- PMID: 35007957
- PMCID: PMC9758363
- DOI: 10.1016/j.drugalcdep.2021.109241
Safer in care: A pandemic-tested model of integrated HIV/OUD care
Abstract
Background: Rural, poor, persons with HIV (PWH) and substance use are among the most vulnerable to SARS-CoV-2 and related health service disruptions. The objective of the study was to evaluate the health outcomes and utilization of PWH at an Outpatient-based Opioid Treatment (OBOT) Clinic.
Methods: We evaluated a clinic-based cohort at the University of Alabama at Birmingham HIV clinic from November 2018 to May 2021. We compared HIV outcomes of OBOT patients, who are highly vulnerable, to the overall clinic. We stratified OBOT patients according to comorbid stimulant use disorder and compared clinic utilization and viral load suppression in the 6 months before and after the safer at home mandate (May 2020) in Alabama.
Results: Of 3857 PWH, 57 were referred to OBOT, 48 attended, 45 were initiated on buprenorphine, and 35 had a VL< 200 in the last 6 months. Relative to the overall HIV clinic, OBOT patients were significantly less likely to remain VL suppressed (90% vs 78%, p = 0.01). More patients were suppressed after OBOT linkage (81%) than prior (73%). For those referred before May 2020, there was no change in viral suppression before and after the safer at home order (75%). Although new OBOT referrals did not increase during the pandemic, the number of visits attended per month did increase from a median of 3-4 per patient.
Conclusions: Unlike many PWH who faced access barriers, PWH receiving care at OBOT did not fall out of care but increased healthcare utilization and maintained viral suppression despite the public health emergency.
Keywords: HIV; Opioid continuum of care; Opioid use disorder; SARS-CoV-2.
Copyright © 2022 Elsevier B.V. All rights reserved.
Figures



Similar articles
-
Primary care and medication management characteristics among patients receiving office-based opioid treatment with buprenorphine.Fam Pract. 2022 Mar 24;39(2):234-240. doi: 10.1093/fampra/cmab166. Fam Pract. 2022. PMID: 34893825 Free PMC article.
-
Patient Barriers and Facilitators to Medications for Opioid Use Disorder in Primary Care.Subst Use Misuse. 2019;54(14):2409-2419. doi: 10.1080/10826084.2019.1653324. Epub 2019 Aug 20. Subst Use Misuse. 2019. PMID: 31429351 Free PMC article.
-
Outcomes of a novel office-based opioid treatment program in an internal medicine resident continuity practice.Addict Sci Clin Pract. 2019 Dec 19;14(1):46. doi: 10.1186/s13722-019-0175-z. Addict Sci Clin Pract. 2019. PMID: 31856915 Free PMC article.
-
Financial sustainability of payment models for office-based opioid treatment in outpatient clinics.Addict Sci Clin Pract. 2021 Jul 5;16(1):45. doi: 10.1186/s13722-021-00253-7. Addict Sci Clin Pract. 2021. PMID: 34225785 Free PMC article. Review.
-
Identification and Management of Opioid Use Disorder in Primary Care: an Update.Curr Psychiatry Rep. 2020 Apr 13;22(5):23. doi: 10.1007/s11920-020-01149-0. Curr Psychiatry Rep. 2020. PMID: 32285215 Review.
Cited by
-
Substance Use Treatment Utilization Among Women With and Without Human Immunodeficiency Virus.Open Forum Infect Dis. 2022 Dec 21;10(1):ofac684. doi: 10.1093/ofid/ofac684. eCollection 2023 Jan. Open Forum Infect Dis. 2022. PMID: 36655189 Free PMC article.
-
Impact of COVID-19 on women living with HIV who are survivors of intimate partner violence.BMC Public Health. 2024 May 20;24(1):1352. doi: 10.1186/s12889-024-18862-7. BMC Public Health. 2024. PMID: 38769576 Free PMC article.
-
Co-Utilization of HIV, Substance Use, Mental Health Services Among Women With Current Substance Use: Opportunities for Integrated Care?J Prim Care Community Health. 2024 Jan-Dec;15:21501319241285531. doi: 10.1177/21501319241285531. J Prim Care Community Health. 2024. PMID: 39327860 Free PMC article.
-
Understanding the impact of the COVID-19 pandemic on substance use and HIV.Drug Alcohol Depend. 2022 Dec 1;241:109688. doi: 10.1016/j.drugalcdep.2022.109688. Epub 2022 Nov 5. Drug Alcohol Depend. 2022. PMID: 36371282 Free PMC article. No abstract available.
-
Expanding access to substance use services and mental health care for people with HIV in Alabama, a technology readiness assessment using a mixed methods approach.BMC Health Serv Res. 2022 Jul 15;22(1):919. doi: 10.1186/s12913-022-08280-z. BMC Health Serv Res. 2022. PMID: 35841096 Free PMC article.
References
-
- Addiction EMCfDaD. European Drug Report 2020: Trends and Developments. Available at: 〈https://www.emcdda.europa.eu/publications/edr/trends-developments/2020_en〉. Accessed April 28, 2021 2021.
-
- Browne T., Priester M.A., Clone S., Iachini A., DeHart D., Hock R. Barriers and facilitators to substance use treatment in the rural south: a qualitative study. J. Rural Health. 2016;32:92–101. - PubMed
-
- Centers for Disease Prevention and Control. Recent HIV Clusters and Outbreaks Across the United States Among People Who Inject Drugs and Considerations During the COVID-19 Pandemic. Available at: 〈https://emergency.cdc.gov/han/2020/han00436.asp〉. Date 10/5/2020. Accessed 1/4/2022.
-
- Centers for Disease Prevention and Control. Overdose Deaths Accelerating During COVID-19. Available at: 〈https://www.cdc.gov/media/releases/2020/p1218-overdose-deaths-covid-19..... Accessed April 7 2021a.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous